BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31324882)

  • 1. Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin.
    Orlik C; Deibel D; Küblbeck J; Balta E; Ganskih S; Habicht J; Niesler B; Schröder-Braunstein J; Schäkel K; Wabnitz G; Samstag Y
    Cell Mol Immunol; 2020 Apr; 17(4):380-394. PubMed ID: 31324882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.
    Chiurchiù V; Rapino C; Talamonti E; Leuti A; Lanuti M; Gueniche A; Jourdain R; Breton L; Maccarrone M
    J Immunol; 2016 Nov; 197(9):3545-3553. PubMed ID: 27694494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress.
    Orlik C; Berschneider KM; Jahraus B; Niesler B; Balta E; Schäkel K; Schröder-Braunstein J; Souto-Carneiro MM; Samstag Y
    Front Immunol; 2022; 13():1016112. PubMed ID: 36353616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.
    Crawford K; Stark A; Kitchens B; Sternheim K; Pantazopoulos V; Triantafellow E; Wang Z; Vasir B; Larsen CE; Gabuzda D; Reinherz E; Alper CA
    Blood; 2003 Sep; 102(5):1745-52. PubMed ID: 12714509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.
    van den Bogaard EH; Tjabringa GS; Joosten I; Vonk-Bergers M; van Rijssen E; Tijssen HJ; Erkens M; Schalkwijk J; Koenen HJPM
    J Invest Dermatol; 2014 Mar; 134(3):719-727. PubMed ID: 24121402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
    Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
    Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ.
    Gunderson AJ; Mohammed J; Horvath FJ; Podolsky MA; Anderson CR; Glick AB
    J Invest Dermatol; 2013 Apr; 133(4):955-63. PubMed ID: 23151849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
    Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
    Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation.
    Mestas J; Hughes CC
    J Immunol; 2001 Oct; 167(8):4378-85. PubMed ID: 11591762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
    Semnani RT; Nutman TB; Hochman P; Shaw S; van Seventer GA
    J Exp Med; 1994 Dec; 180(6):2125-35. PubMed ID: 7525848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
    Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
    Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
    Farkas A; Kemény L
    Int Immunopharmacol; 2012 Jun; 13(2):215-8. PubMed ID: 22522054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
    Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ
    J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
    Tian X; Tang L; Wei F; Chen H; Sheng L; Yang Y; Zhou X; Li Y; Xu X; Zhang B; Liu Z; Lei Y; Yu B; Bai C; He X; Huang Z
    Mol Immunol; 2021 Apr; 132():30-40. PubMed ID: 33540227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes.
    Pennino D; Eyerich K; Scarponi C; Carbone T; Eyerich S; Nasorri F; Garcovich S; Traidl-Hoffmann C; Albanesi C; Cavani A
    J Immunol; 2010 May; 184(9):4880-8. PubMed ID: 20357258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.